Moxaclav Injection

About Moxaclav 500 mg + 100 mg Injection

Moxaclav Injection is an antibiotic used to treat bacterial infections. It combines amoxicillin with clavulanic acid and is given by a healthcare professional. The doctor decides the dose and course.

There are 105 brands of Amoxicillin + Clavulanic Acid listed in Bangladesh. The lowest listed price is Moxilin CV 125 mg + 31.25 mg/5 ml Powder For Suspension at ৳ 1 per unit.

What is Moxaclav 500 mg + 100 mg Injection?

Moxaclav Injection contains amoxicillin, a penicillin antibiotic, and clavulanic acid, which blocks enzymes that can make bacteria resistant to amoxicillin. It is used for short-term treatment of bacterial infections in the upper and lower respiratory tract, such as tonsillitis, sinusitis, and pneumonia, and in the urinary tract, such as cystitis. The injection is given by a healthcare professional. The doctor will decide the appropriate dose and duration for each patient. Moxaclav is available as a 500 mg + 100 mg injection from Square Pharmaceuticals PLC.

Uses of Moxaclav

Moxaclav Injection is used to treat short-term bacterial infections. These include upper respiratory tract infections such as tonsillitis, sinusitis, and otitis media, lower respiratory tract infections such as acute and chronic bronchitis and pneumonia, and genito-urinary tract infections such as cystitis. It is not for viral infections like the common cold. The doctor will determine if this antibiotic is suitable for the infection.

How to use Moxaclav

Moxaclav Injection is given by a healthcare professional, usually as an injection into a vein or muscle. The dose and how often it is given are decided by the doctor based on the type and severity of the infection, the patient's age, weight, and kidney function. The course should be completed as prescribed. Do not attempt to self-administer. Ask the doctor or pharmacist if you have questions about how it is given.

Side effects of Moxaclav

Side effects with Moxaclav are generally mild and short-lived. Common ones include diarrhoea, indigestion, nausea, vomiting, and candidiasis. Rashes may occur. Rarely, hepatitis and cholestatic jaundice have been reported, usually reversible. Serious allergic reactions such as angioedema and anaphylaxis are rare but need immediate medical attention. If you notice any side effects, tell your doctor or nurse.

Safety and precautions

Moxaclav should not be used by anyone with a history of penicillin allergy or a previous history of jaundice associated with co-amoxiclav or penicillin. Caution is needed in patients with severe liver problems or those taking anticoagulants. The dose may need adjustment in kidney impairment. Use in pregnancy is not recommended unless the doctor considers it essential. Small amounts may pass into breast milk. Always tell your doctor about allergies, other medicines, and health conditions before receiving this injection.

Frequently asked questions

How is Moxaclav Injection given?

It is given by a healthcare professional as an injection. The doctor decides the dose, frequency, and duration based on your infection and health. Do not try to inject it yourself. Follow the doctor's instructions and complete the course as prescribed.

What is Moxaclav Injection used for and what kind of medicine is it?

It is an antibiotic used for short-term treatment of certain bacterial infections, including respiratory tract infections like sinusitis and pneumonia, and urinary tract infections like cystitis. It contains amoxicillin and clavulanic acid and does not work for viral infections such as colds.

Who should avoid Moxaclav Injection or ask the doctor first?

People allergic to penicillin or with a history of jaundice from co-amoxiclav or penicillin should not use it. Those with liver or kidney problems, pregnant or breastfeeding women, or people taking blood thinners should inform the doctor before treatment.

What should I do if I miss a dose?

Since Moxaclav Injection is given by a healthcare professional, missed doses are managed by them. If you are receiving it in a hospital or clinic, the staff will follow the schedule. Ask your doctor or nurse for advice if you have concerns about timing.

Indications

Co-amoxiclav is indicated for short-term treatment of bacterial infections at the following sites:
  • Upper respiratory tract infections (including ENT) e.g.tonsillitis,sinusitis,otitis media.
  • Lower respiratory tract infections e.g.acute and chronic bronchitis, lobar and bronchopneumonia.
  • ... Read more
Co-amoxiclav is indicated for short-term treatment of bacterial infections at the following sites:
  • Upper respiratory tract infections (including ENT) e.g.tonsillitis,sinusitis,otitis media.
  • Lower respiratory tract infections e.g.acute and chronic bronchitis, lobar and bronchopneumonia.
  • Genito-urinary tract infections e.g.cystitis,urethritis,pyelonephritis.
  • Skin and soft tissue infections.
  • Bone and joint infections e.g.osteomyelitis.
  • Other infections e.g.septic abortion,puerperal sepsis,intra-abdominal sepsis etc.

Pharmacology

Pharmacodynamic properties: Co-amoxiclav is an antibacterial combination consisting of the antibiotic Amoxicillin and the (3-lactamase inhibitor Clavulanic Acid. Amoxicillin has a broad spectrum of bactericidal activity against many Gram-positive & Gram-negative microorganisms but it is susceptible to degradation by (3-lactamases and therefore the spectrum of activity does not include microorganisms, which produce these enzymes. Clavulanic acid possesses the ability to inactivate a wide range of beta-lactamase enzymes commonly found in microorganisms resistant to penicillins and cephalosporins. Thus Clavulanic acid in this preparation protects Amoxicillin from degradation by (3-lactamase enzymes and effectively extends the antibiotic spectrum to embrace a wide range of microorganisms.

Pharmacokinetic properties: The pharmacokinetics of the two components of Co-amoxiclav is closely matched. Peak serum levels of both occur about one hour after oral administration. Absorption of Co-amoxiclav is optimized at the start of a meal. Both clavulanate and Amoxicillin have low levels of serum binding; about 70% remains free in the serum. Doubling the dosage of Co-amoxiclav approximately doubles the serum levels achieved.

Dosage & Administration

Adults and children over 12 years:

Tablet:
  • The usual adult dose is one 625 mg Tablet every 12 hours or one 375 mg Tablet every 8 hours.
  • For more severe infections and infections of the respiratory tract, the dose should be one 1 gm Tablet every 12 hours or one 625 mg Tablet every 8 hours.
Suspension:
  • Children 6-12 years: 2 teaspoonful every 8 hours.
  • Children 1-6years: 1 teaspoonful every 8 hours.
  • Children below 1 year: 25 mg/kg/day in divided doses every 8 hours, for example a 7.5 kg child would require 2 ml suspension t.i.d, Treatment should not be extended beyond 14 days without review.
Forte suspension:
  • The usual recommended daily dosage: 25/3.6 mg/kg/day in mild to moderate infections (upper respiratory tract infections e.g. recurrent tonsilitis, lower respiratory infections, and skin and soft tissue infections)।
  • For serious infections: 45/6.4 mg/kg/day for the treatment of more serious infections (upper respiratory tract infections, e.g. otitis media and sinusitis, lower respiratory infections e.g. bronchopneumonia, and urinary tract infections).
Children of 2 to 12 years:
Mild to moderate infections:
  • 25/3.6 mg/kg/day (Suspension)
  • 2-6 years (13-21 kg) 2.5 ml suspension b.i.d
  • 7-12years (22-40kg) 5 ml suspension b.i.d
Serious infections:
  • 45/6.4 mg/kg/day (Forte Suspension)
  • 2-6 years (13-21 kg) 5 ml suspension b.i.d
  • 7-12 years (22-40 kg) 10 ml suspension b.i.d
IV Injection

Adults-
  • Usually, 1.2 gm every 8 hours
  • Increased in more serious infections to 1.2 gm every 6 hours
  • For surgical prophylaxis: The usual dose is 1.2 gm at induction, for high risk procedures (eg. colorectal surgery) up to 2-3 gm may be given every 8 hours.
Children-
  • 0 to 3 months: 30 mg/kg every 8 hours. (every 12 hours in the perinatal period and in premature infants.
  • 3 months to 12 years: Usually 30 mg/kg every 8 hours increased in more serious infection to 30 mg/kg every 6 hours.

Interaction

Prolongation of bleeding time and prothrombin time have been reported in some patients receiving Co-amoxiclav. In common with other broad-spectrum antibiotics, Co-amoxiclav may reduce the efficacy of oral contraceptives and patients should be warned accordingly. Concomitant use of allopurinol during treatment with amoxicillin can increase the likelihood of allergic skin reactions. There are no data on the concomitant use of Co-amoxiclav and allopurinol.

Contraindications

History of Penicillin hypersensitivity. Attention should be paid to possible cross-sensitivity with other beta-lactam antibiotics e.g. cephalosporins. Also contraindicated for patients with a previous history of Co-amoxiclav or Penicillin-associated cholestatic jaundice.

Side Effects

Side effects, as with Amoxicillin, are uncommon and mainly of a mild and transitory nature. Diarrhoea, pseudomembranous colitis, indigestion, nausea, vomiting and candidiasis have been reported, if gastrointestinal side effects occur with oral therapy, that may be reduced by taking Co-amoxiclav at the start of meals. Hepatitis and cholestatic jaundice have been reported rarely but are usually reversible. Urticarial and erythematous rashes sometimes occur. Rarely erythema multiforme, Stevens-Johnson Syndrome and exfoliative dermatitis have been reported. In common with other beta-lactam antibiotics, angioedema and anaphylaxis have been reported.

Pregnancy & Lactation

Animal studies with orally and parenterally administered Co-amoxiclav have shown no teratogenic effect. The drug has been used orally in human pregnancy in a limited number of cases with no untoward effect; however, the use of Co-amoxiclav in pregnancy is not recommended unless considered essential by the physician. During lactation, trace quantities of Amoxicillin can be detected in breast milk.

Precautions & Warnings

Co-amoxiclav should be used with care in patients on anticoagulation therapy or with severe hepatic dysfunction. In patients with moderate or severe renal impairment, dosage should be adjusted. During the administration of a high dose of Co-amoxiclav adequate fluid intake and urinary output should be maintained to minimize the possibility of crystalluria.

Overdose Effects

Problems of overdose with Co-amoxiclav are unlikely to occur, if encountered gastrointestinal symptoms and disturbance of the fluid and electrolyte balances may be evident. Co-amoxiclav may be removed from the circulation by haemodialysis.

Storage Conditions

This should be stored below 25°C, protected from light and moisture. Once reconstituted suspension should be kept in the refrigerator (but not frozen) and should be usedby 7 days. Once reconstituted vial must be used within 20 minutes.

Alternative brands of Amoxicillin + Clavulanic Acid

Other brands with the same generic name, cheapest first.

See all 105 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.